Trimoulet, Pascale

Publishing since 1999 (Senior)

Has published 31 publications in 11 years

Number of publications published per year by Trimoulet, Pascale. (Source : PubMed)

Distribution of publications types for Trimoulet, Pascale. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix ML, Hézode C, Foucher J, Fontaine H, Roque-Afonso AM, Gassin M, Schvoerer E, Gaudy C, Roche B, Doffoël M, D'Alteroche L, Vallet S, Baazia Y, Pozzetto B, Thibault V, Nousbaum JB, Roulot D, Coppere H, Poinard T, Payan C, Izopet J. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.  J. Med. Virol.  2009;81;12  
•  Breilh D, Djabarouti S, Trimoulet P, Le Bail B, Dupon M, Ragnaud JM, Fleury H, Saux MC, Thiébaut R, Chêne G, Neau D. Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.  J. Acquir. Immune Defic. Syndr.  2009;52;3  
•  Kantelhardt VC, Schwarz A, Wend U, Schüttler CG, Willems WR, Trimoulet P, Fleury H, Gerlich WH, Kann M. Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.  J. Clin. Virol.  2009;46;2  
•  Breilh D, Foucher J, Castéra L, Trimoulet P, Djabarouti S, Merrouche W, Couzigou P, Saux MC, de Lédinghen V. Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C.  Aliment. Pharmacol. Ther.  2009;30;5  
•  Neau D, Trimoulet P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, Dupon M, Ecobichon JL, Chêne G, Raffi F. Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.  J. Acquir. Immune Defic. Syndr.  2008;48;2  
•  Masante C, Mahias K, Lourenço S, Dumas E, Cahour A, Trimoulet P, Fleury H, Astier-Gin T, Ventura M. Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication.  J. Gen. Virol.  2008;89;Pt 1  
•  Trimoulet P, Boutonnet M, Winnock M, Faure M, Loko MA, De Lédinghen V, Bernard PH, Castéra L, Foucher J, Dupon M, Ragnaud JM, Lafon ME, Couzigou P, Dabis F, Fleury H, Neau D. Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.  Gastroenterol. Clin. Biol.  2007;31;12  
•  Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.  Aliment. Pharmacol. Ther.  2007;26;11-12  
•  de Lédinghen V, Trimoulet P, Mannant PR, Dumas F, Champbenoît P, Baldit C, Foucher J, Faure M, Vergniol J, Castéra L, Bertet J, Fleury H, Couzigou P, Bernard PH. Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).  J. Hepatol.  2007;46;1  
•  Benhamou Y, Fleury H, Trimoulet P, Pellegrin I, Urbinelli R, Katlama C, Rozenbaum W, Le Teuff G, Trylesinski A, Piketty C. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.  Hepatology  2006;43;3  

[ See timeline ] [ See all publications ]